Quick Answer
ORAGENICS INC reported R&D Expense of $2.39 million for fiscal year 2025.
ORAGENICS INC R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $2.39M | -41.8% |
| 2024 | $4.11M | -73.4% |
| 2023 | $15.49M | +53.8% |
| 2022 | $10.07M | -4.9% |
| 2021 | $10.59M | -52.1% |
| 2020 | $22.11M | +82.4% |
| 2019 | $12.12M | +103.0% |
| 2018 | $5.97M | +68.7% |
| 2017 | $3.54M | -25.6% |
| 2016 | $4.75M | -45.6% |
| 2015 | $8.73M | +184.9% |
| 2014 | $3.07M | -67.3% |
| 2013 | $9.36M | +19.1% |
| 2012 | $7.86M | +221.0% |
| 2011 | $2.45M | +21.6% |
| 2010 | $2.01M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $930.9K | +5.9% | +107.0% |
| June 30, 2025 | $449.7K | -50.4% | +31.7% |
| March 31, 2025 | $341.5K | -48.5% | -61.1% |
| September 30, 2024 | $879.0K | +14.3% | -3.1% |
| June 30, 2024 | $906.8K | -54.8% | +36.7% |
| March 31, 2024 | $663.4K | -60.3% | -13.8% |
| September 30, 2023 | $769.4K | -72.3% | -61.7% |
| June 30, 2023 | $2.01M | -22.5% | +20.0% |
- ORAGENICS INC showed a decrease of -41.8% in R&D Expense compared to the prior fiscal year.
- Over the 2010–2025 period, ORAGENICS INC’s r&d expense has grown by 18.8% (from $2.01 million to $2.39 million).
- The most recent figure is from ORAGENICS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 16, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: